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delivered by an Elekta Agility linear accelerator to a moving 
anatomy.  
 
Material and Methods: A Quasar respiratory motion 
programmable phantom (Modus Medical) with a lung insert 
containing a 3 cm diameter tumour was used for dose 
measurements. Measurements were performed on an Elekta 
Agility linac with the phantom in static and moving 
(sinusoidal motion, 1.8 cm respiratory amplitude) states. 
Dose to the centre of the tumor was measured using 
calibrated EBT3 film and the RADPOS 4D dosimetry system. 
The RADPOS position tracker recorded the phantom motion 
with time steps of 100 ms. Static and 4DCT scans of the 
Quasar phantom were acquired using a helical CT scanner 
(Brilliance CT Big Bore). A single 6 MV 4x4 cm2 square field 
covering the tumour was planned on the static CT scans using 
the Elekta XiO V.4.7 treatment planning system. A previously 
validated BEAMnrc model of our Elekta Agility linac was used 
for all simulations. The DOSXYZnrc and defDOSXYZnrc user 
codes were used, respectively, for static and moving anatomy 
dose simulations with 500,000,000 histories to achieve a 
statistical uncertainty of 0.4%. The defDOSXYZnrc code was 
modified to sample a new geometry for each incident 
particle, thereby simulating the continuous phantom motion. 
The treatment plan was exported from XiO as DICOM format 
and a Python script was used to extract the data and 
generate input files for MC simulations. An egsphant file with 
0.1250 x 0.1250 x 0.1 cm3 resolution was generated from 
static CT scans for all simulations. The multipass deformable 
image registration algorithm in Velocity (Varian Medical 
Systems) V.3.0.1 was used to register the CT image of the 
phantom in end-of-exhale state to the static CT image. For 
4D simulations, deformation vectors from Velocity were input 
to the defDOSXYZnrc code as well as the phantom motion 
trace measured with RADPOS. To examine the impact of 
deformable registration accuracy, 4D simulations were also 
performed using manually generated deformation vectors 
that exactly modelled the rigid translation of the lung insert.  
 
Results: Table 1 shows the calculated and measured tumor 
doses and their uncertainties. Calculated dose for the moving 
anatomy using vectors generated by Velocity was 75.9 
cGy±0.4% that is 0.5% lower than the similar calculation using 
manually generated vectors. 
Table 1. Calculated and measured tumor doses and their 
uncertainties 
 
 
Figure 1 shows the calculated and measured tumor profiles
 
 
Fig1. Comparison of simulated (MC with manually generated 
vectors) and measured (Film) dose profiles for static (left) 
and moving (right) states.  
. 
Conclusion: The level of agreement between MC Simulation 
results and measurements is within 2%. This makes our 4D 
Monte Carlo simulations using the defDOSXYZnrc code an 
accurate and reliable method to calculate dose delivered to a 
moving anatomy. 
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Purpose or Objective: Determining whether individual 
treatment plans are near optimal is important for routine 
clinical care and clinical studies. However, plan quality 
assurance (QA) is difficult, time consuming and operator 
dependent. Furthermore, applying checklists of generic QA 
parameters to all patients cannot accurately gauge the 
quality of individual patient plans. RapidPlan (Varian Medical 
Systems, Palo Alto, USA), a commercial knowledge-based 
planning solution, could automate individualized plan QA by 
benchmarking the plan against predicted patient-specific 
organ-at-risk (OAR) doses derived from a library of plans that 
consists of various OAR-planning target volume (PTV) 
geometries and associated dose distributions. Using 
RapidPlan for this purpose requires that the predicted doses 
are achievable when RapidPlan is subsequently used to 
generate a plan. This was investigated for locally advanced 
head and neck cancer. 
 
Material and Methods: A RapidPlan model consisting of 90 
plans, generated using previously created automatically 
optimized plans, was used to predict achievable OAR dose-
volume histograms (DVHs) for the parotid glands, 
submandibular glands, individual swallowing muscles and oral 
cavities of 20 HNC patients. Differences between the 
achieved and predicted DVH-lines were analyzed for all OARs. 
To illustrate the possible gains that individualized plan QA 
could realize, the RapidPlan predictions were used to 
evaluate achieved OAR sparing of an evaluation group (EG) of 
20 manually interactively optimized plans. 
 
Results: The Figure shows strong linear correlations (solid 
lines, R²=0.94-0.99) found between the predicted and 
achieved mean doses for all OARs, demonstrating the 
accuracy of the RapidPlan DVH predictions. The dashed lines 
have a slope of 1 and run through the origin, meaning that 
for OARs on this line, the mean dose predicted by RapidPlan 
was exactly achieved. More detailed analysis of the predicted 
and achieved DVHs showed that at higher dose regions (OAR 
volumes <30%), the amount of achievable sparing is 
underestimated for OARs with mean doses <20Gy while it is 
progressively overestimated for OARs with higher mean 
doses. Using the predicted OAR DVHs identified that for 10 
plans in the EG, sparing of the composite (volume weighted) 
salivary glands, oral cavity or composite swallowing muscles 
could be improved by at least 3Gy, 5Gy or 7Gy, respectively. 
These predicted gains were confirmed by replanning the 
identified patients using RapidPlan. 
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Conclusion: Strong correlations between predicted and 
achieved mean OAR doses indicates that RapidPlan could 
accurately predict achievable mean doses, showing the 
feasibility of using RapidPlan DVH predictions alone for 
automated individualized HNC plan QA. Since this QA 
approach does not require the creation of additional plans, 
these findings indicate that automated individualized plan QA 
is now a realistic proposition for individual centers and 
clinical trials. 
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Purpose or Objective: Image guided robotic stereotactic 
radiotherapy (SRT) is becoming increasingly commonly used 
in the treatment of prostate cancer. As SRT treatment may 
consist of 100-300 small beams, the dose-rate (DR) and thus 
the biologically effective dose (BED) can vary significantly 
within the target volume, despite the creation of a very 
uniform total physical dose distribution (1). However, the 
significance of the spatial variations in DR on BED in robotic 
SRT treatments remains unknown.  
The aim of the present study is to measure the DR 
distribution, with treatment progression, in a representative 
robotic SRT treatment for prostate cancer and to investigate 
the effect of these spatial and time related variations in the 
measured DR on the calculated BED. 
 
Material and Methods: A representative robotic SRT 
treatment plan for prostate cancer (5 x 7.25 Gy, 222 beams, 
treatment time 28 min) was created with the Multiplan 
treatment planning software (v 4.6.0., Accuray, USA). Based 
on this plan a quality assurance plan was calculated for a 
MultiCube phantom incorporating a MatriXX Detector (32 x 32 
matrix of ionization chambers) spatial resolution 7.6 mm, 
time resolution 0.5 s (IBA Dosimetry, Germany). The DR 
distributions were measured in four different coronal planes 
(separated by 1cm) covering the volume of the target 
structure to create a 3D DR distribution. Then BED values, 
calculated using bi-exponential repair (repair half times 0.2 h 
and 2.5 h, α/β =1.5Gy) were calculated for each voxel based 
on the measured DR (BED_M), average dose-rate (measured 
dose divided by the overall treatment time, BED_A) and 
physical dose (measured dose without the repair component, 
BED_P) distributions.  
 
Results: Compared to the BED_P, where no repair was 
allowed for, both BED_M and BED_A values, within the target 
volume, were significantly lower (Fig 1). Furthermore, BED_M 
values were found to be systematically higher than BED_A 
values. Significant variation was observed in BED_M values 
corresponding to the same BED_P value (Fig 1). This effect 
was not observed with BED_A values (Fig 1). 
 
 
 
Figure 1. A: Representative SRT plan, B: corresponding BED_P 
values, C: Frequency distributions of BED_P, BED_M and 
BED_A values within the target volume, D: Range of BED_M or 
BED_A values corresponding uniform BED_P value.  
 
Conclusion: The simple us of the average DR in the 
determination of BED does not take into account the 
variations in the spatial DR, and this leads to an 
underestimation of BED values. Furthermore, significant 
variations were observed in BED_M values when compared to 
uniform BED_P values, an observation also consistent with 
comparable Gamma Knife treatments (1). Thus, the actual 
and not the average DR should be used in the calculation of 
BED when the efficacy of the SRT treatments is evaluated or 
different treatment modalities are compared. 
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Learning Objectives 
 
At the end of this talkyou will have a better awareness of: 
1. reasons why educational ‘science’ may be overlooked 
2. how principles of adult learning might apply to radiation 
oncology 
3. potential benefits of applying an evidence-based approach 
to educationalactivities  
Radiation Oncology is adiscipline with a history firmly 
founded on the sciences of radiobiology,radiation physics, 
anatomy, pathology and clinical medicine that remain 
asrelevant as ever to its exciting future. An evidence-based 
approach to practiceand progress in our field is seen as core 
to our identity as radiation oncologyprofessionals. 
So how can it be thatthe ‘science’ of teaching the next 
generation of practitioners, as well as thecurrent one 
(ourselves), especially in such a rapidly changing arena, is 
oftenleft to chance? Why is so little focus placedon the 
